BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8151322)

  • 1. Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma.
    Johnson PW; Price CG; Smith T; Cotter FE; Meerabux J; Rohatiner AZ; Young BD; Lister TA
    J Clin Oncol; 1994 Apr; 12(4):798-805. PubMed ID: 8151322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment.
    Pappa VI; Wilkes S; Salam A; Young BD; Lister TA; Rohatiner AZ
    Bone Marrow Transplant; 1998 Sep; 22(6):553-8. PubMed ID: 9758342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.
    Rohatiner AZ; Johnson PW; Price CG; Arnott SJ; Amess JA; Norton AJ; Dorey E; Adams K; Whelan JS; Matthews J
    J Clin Oncol; 1994 Jun; 12(6):1177-84. PubMed ID: 8201380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation.
    Hirt C; Dölken G
    Bone Marrow Transplant; 2000 Feb; 25(4):419-26. PubMed ID: 10723586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
    Rohatiner AZ; Nadler L; Davies AJ; Apostolidis J; Neuberg D; Matthews J; Gribben JG; Mauch PM; Lister TA; Freedman AS
    J Clin Oncol; 2007 Jun; 25(18):2554-9. PubMed ID: 17515573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations.
    Negrin RS; Pesando J
    J Clin Oncol; 1994 May; 12(5):1021-7. PubMed ID: 8164025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up.
    Apostolidis J; Gupta RK; Grenzelias D; Johnson PW; Pappa VI; Summers KE; Salam A; Adams K; Norton AJ; Amess JA; Matthews J; Bradburn M; Lister TA; Rohatiner AZ
    J Clin Oncol; 2000 Feb; 18(3):527-36. PubMed ID: 10653868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma.
    Haas R; Moos M; Karcher A; Möhle R; Witt B; Goldschmidt H; Frühauf S; Flentje M; Wannenmacher M; Hunstein W
    J Clin Oncol; 1994 Aug; 12(8):1685-92. PubMed ID: 7518860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloablative therapy with autologous bone marrow transplantation as consolidation of remission in patients with follicular lymphoma.
    Rohatiner AZ; Price CG; Arnott S; Norton A; Evans ML; Cotter F; Dorey E; Davis CL; Clark P; Sterlini J
    Ann Oncol; 1991 Feb; 2 Suppl 2():147-50. PubMed ID: 2049312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
    Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
    Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma.
    Berinstein NL; Reis MD; Ngan BY; Sawka CA; Jamal HH; Kuzniar B
    J Clin Oncol; 1993 Jul; 11(7):1344-52. PubMed ID: 8315432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
    Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).
    Ha CS; Tucker SL; Lee MS; McLaughlin P; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):727-32. PubMed ID: 11172955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach.
    Deggerdal AH; Pettersen F; Kvalheim G; Hornes E; Smeland E; Fodstad O; Hovig E
    Lab Invest; 1995 Apr; 72(4):411-8. PubMed ID: 7723279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma.
    Rohatiner AZ; Freedman A; Nadler L; Lim J; Lister TA
    Ann Oncol; 1994; 5 Suppl 2():143-6. PubMed ID: 8204513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) in a patient before and after allogeneic bone marrow transplantation.
    Meijerink JP; Goverde GJ; Smetsers TF; Raemaekers JM; Bogman MJ; de Witte T; Mensink EJ
    Ann Oncol; 1994; 5 Suppl 1():43-5. PubMed ID: 8172816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative preclinical study of three bone marrow purging methods using PCR evaluation of residual t(14;18) lymphoma cells.
    Yerly-Motta V; Racadot E; Fest T; Bastard C; Ferrand C; Deschaseaux ML; Herve P
    Leuk Lymphoma; 1996 Oct; 23(3-4):313-21. PubMed ID: 9031112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma.
    Paszkiewicz-Kozik E; Kulik J; Fabisiewicz A; Tysarowski A; Kraszewska E; Siedlecki JA; Walewski J
    Med Oncol; 2009; 26(1):16-21. PubMed ID: 18470485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma.
    Gribben JG; Freedman AS; Neuberg D; Roy DC; Blake KW; Woo SD; Grossbard ML; Rabinowe SN; Coral F; Freeman GJ
    N Engl J Med; 1991 Nov; 325(22):1525-33. PubMed ID: 1944436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.